All financings
COMPANY TRANSACTIONS

SeaStar Medical Holding Corp.

ICUNasdaqBiotechnology

Deal details

1 transaction in the database

TRANSACTION REPORT · SEC DISCLOSURES

Deal notes

ContextDeal context

The $3.3 million is cash raised by exercising 854,002 existing warrants at $3.866. Four original cohorts had strikes of $6.38–$7.62; the filings do not allocate the exercises among those cohorts. Two new investor warrant series total 1,708,004 shares at $3.616, with different expiry terms. Agent warrants are separate compensation.

Original source ↗
Gross proceeds$3.3M
Offering price—
Discount to prior close—
Warrant coverage200%
Placement agent / underwriterH.C. Wainwright

Transaction overview

01

SeaStar Medical Holding Corp completed a $3.3M warrant exercise / inducement. H.C. Wainwright acted as exclusive placement agent for the financing.

Financing type
Warrant Exercise / Inducement
Announcement date
Oct 5, 2026
Agreement date
Oct 2, 2026
Pricing date
—
Closing date
Oct 5, 2026
Filing date
Oct 5, 2026
Status
Closed
Market cap before announcement
$19.2M
Prior closing price
$4.69
Raise as % of market cap
17.2%

Market data · FMP

Historical market cap
$19,155,287
Market date
Oct 2, 2026
Closing price
$4.69
Latest reported shares outstanding
2,837,944
Latest reported float shares
2,818,545
Share-data date
Oct 8, 2026

Market cap and closing price are from FMP for the date shown. Shares are FMP’s latest available snapshot, dated separately. Updated Oct 9, 2026.

Financial Modeling Prep ↗

Financing terms

02

Warrant exercise / inducement

Warrants exercised
854,002
Original exercise price
Varies by original cohort
Exercise price paid
$3.866
Cash proceeds
$3.3M

Security structure

Price / security basis
Common shares
Units offered
—
Preferred class
Not applicable
Preferred shares offered
—

Original warrant cohorts

June 2025 — expires June 2030

Originally issued
Jun 23, 2025
Original exercise price
$6.50
Exercised from this cohort
—

June 2025 — expires December 2026

Originally issued
Jun 23, 2025
Original exercise price
$6.50
Exercised from this cohort
—

July 2025 — expires August 2030

Originally issued
Jul 11, 2025
Original exercise price
$6.38
Exercised from this cohort
—

August 2025 — expires August 2030

Originally issued
Aug 1, 2025
Original exercise price
$7.62
Exercised from this cohort
—

The filings disclose 854,002 exercises in aggregate but do not allocate that count among the four original warrant cohorts. Original strikes and issuance dates are retained separately.

New Series A warrants

Warrant shares
854,002
Cash exercise price
$3.616
Term
Five years from effectiveness of the resale registration statement; immediately exercisable.
Initial exercisability
—
Beneficial ownership limits
—

New Series B warrants

Warrant shares
854,002
Cash exercise price
$3.616
Term
Eighteen months from effectiveness of the resale registration statement; immediately exercisable.
Initial exercisability
—
Beneficial ownership limits
—

Placement agent warrants

Warrant shares
59,780
Cash exercise price
$4.8325
Term
Five years from effectiveness of the resale registration statement; immediately exercisable.
Initial exercisability
—
Beneficial ownership limits
—

Compensation warrants are excluded from investor warrant coverage.

Fees & transaction economics

03
Placement agent / underwriting fee
7%
Agent fee amount
$231,000
Management fee
1%
Other offering expenses (estimated)
$90,950
Net proceeds (estimated)
—
Net proceeds as % of gross
—

Fee amounts reflect disclosed inputs. Unknown expense components are not assumed to be zero.

7% cash placement fee plus 1% management fee; $75,000 non-accountable expenses and $15,950 clearing fee. Agent warrants are separate compensation.

Transaction participants

04
Investor names: —

Source documents

05

SEC filings, exhibits and attributed market data. The report separates disclosed facts, calculated metrics, and unknown terms.

EX-4.1 · SeaStar Medical Holding CorpSEC filing · Oct 5, 2026
Open source ↗
EX-4.2 · SeaStar Medical Holding CorpSEC filing · Oct 5, 2026
Open source ↗
EX-4.3 · SeaStar Medical Holding CorpSEC filing · Oct 5, 2026
Open source ↗
EX-10.1 · SeaStar Medical Holding CorpSEC filing · Oct 5, 2026
Open source ↗
EX-99.1 · SeaStar Medical Holding CorpSEC filing · Oct 5, 2026
Open source ↗
8-K · SeaStar Medical Holding CorpSEC filing · Oct 5, 2026
Open source ↗
FMP historical market data · ICUMarket data · Oct 2, 2026
Open source ↗
D · SeaStar Medical Holding CorpSEC filing · Oct 8, 2026
Open source ↗
SEC deal terms · FMP market data where available · Initial research sample, not complete market coverage. AI-assisted source review; original evidence is available in each report. Names and tickers reflect the transaction date. A dash (—) means the value is unavailable.